Target intelligence / Profile preview

Cellular oxidative stress pathways in vascular smooth muscle cells

Molecular classification
Other
01

Overview

Cellular oxidative stress pathways in vascular smooth muscle cells (VSMCs) represent a complex network of biochemical processes that regulate the balance between reactive oxygen species (ROS) production and antioxidant defense mechanisms [1]. In VSMCs, ROS are primarily generated by enzymes such as NADPH oxidases (NOX1, NOX4), mitochondria, and xanthine oxidase in response to stimuli like angiotensin II, growth factors, and mechanical strain [2]. While physiological levels of ROS act as critical secondary messengers in signal transduction, an imbalance leading to oxidative stress promotes VSMC hypertrophy, migration, and phenotypic switching [3]. These cellular changes are fundamental drivers of vascular pathologies, including hypertension, atherosclerosis, and restenosis after angioplasty [4]. Therapeutic strategies often focus on specific components of these pathways, such as inhibiting NOX enzymes or activating the Nrf2-mediated antioxidant response, to mitigate oxidative damage and restore vascular function [5]. However, the complexity and redundancy of these pathways, along with the dual role of ROS in both health and disease, present significant challenges for therapeutic development [1].

Other names
VSMC oxidative stressVascular smooth muscle redox signalingOxidative stress in vascular smooth muscleROS signaling in smooth muscle cells
02

Mechanism of action

Modulation of reactive oxygen species (ROS) production through inhibition of enzymes like NADPH oxidase or enhancement of antioxidant defenses via Nrf2 activation.

03

Biological functions

Signal transductionCell proliferationCell deathCell migrationOther
04

Disease associations

Cardiovascular diseaseInflammationOther
05

Safety considerations

Interference with physiological ROS signalingPotential for pro-oxidant effects at high dosesLack of tissue specificity leading to systemic side effects
06

Interacting drugs

Setanaxib (GKT137831)

4 more in the full profile.

07

Biomarkers

8-IsoprostaneMalondialdehyde (MDA)3-NitrotyrosineSuperoxide dismutase (SOD) activityGlutathione (GSH/GSSG) ratio

Beyond the preview

Go deeper on Cellular oxidative stress pathways in vascular smooth muscle cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular oxidative stress pathways in vascular smooth muscle cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call